Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

Current human immunodeficiency virus type 1 (HIV-1) envelope vaccine candidates elicit high antibody binding titers with neutralizing activity against T-cell line-adapted but not primary HIV-1 isolates. Serum antibodies from these human vaccine recipients were also found to be preferentially directe...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	J Virol
Egile Nagusiak:	VanCott, T C, Mascola, J R, Kaminski, R W, Kalyanaraman, V, Hallberg, P L, Burnett, P R, Ulrich, J T, Rechtman, D J, Birx, D L
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1997
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191648/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9151820/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.6.4319-4330.1997
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

Antzeko izenburuak